Sugi Predict

Sugi Predict / Compounds / SCHEMBL3029762

SCHEMBL3029762

SCHEMBL3029762

CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccc(F)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.76
▸ ALDH1A1 P00352 3/20 0.76
▸ TSHR P16473 1/20 0.76
▸ SMN1; SMN2 Q16637 1/20 0.76
▸ ABCC1 P33527 1/20 0.74
▸ HPGD P15428 2/20 0.72
▸ HSD17B10 Q99714 2/20 0.72
▸ GAA P10253 2/20 0.72
▸ LMNA P02545 2/20 0.72
▸ CACNA1F O60840 1/20 0.68
▸ CACNA1D Q01668 1/20 0.68
▸ CACNA1S Q13698 1/20 0.68
▸ CACNA1C Q13936 1/20 0.68
▸ ADORA3 P0DMS8 2/20 0.66
▸ MTOR P42345 1/20 0.61
▸ RAB9A P51151 1/20 0.61
▸ ACHE P22303 1/20 0.56
▸ TP53 P04637 1/20 0.56
▸ HRH3 Q9Y5N1 1/20 0.55
▸ MAPT P10636 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7817206 0.92 KDM4E (0.88) KDM4EALDH1A1TSHRSMN1; SMN2ABCC1
SCHEMBL11521734 0.89 KDM4E (0.61) KDM4EALDH1A1TSHRSMN1; SMN2ABCC1
SCHEMBL3032293 0.88 KDM4E (0.80) KDM4EALDH1A1TSHRSMN1; SMN2ABCC1
SCHEMBL7368284 0.86 KDM4E (1.00) KDM4EALDH1A1TSHRSMN1; SMN2ABCC1
SCHEMBL3017205 0.85 KDM4E (0.76) KDM4EALDH1A1TSHRSMN1; SMN2ABCC1
SCHEMBL3030945 0.85 ABCC1 (1.00) KDM4EALDH1A1TSHRSMN1; SMN2ABCC1
SCHEMBL7879285 0.84 CACNA1F (0.76) KDM4EALDH1A1TSHRSMN1; SMN2ABCC1
SCHEMBL3027412 0.84 ADORA3 (0.89) KDM4EALDH1A1TSHRSMN1; SMN2ABCC1
SCHEMBL11820276 0.84 KDM4E (0.70) KDM4EALDH1A1TSHRSMN1; SMN2ABCC1
SCHEMBL8222599 0.84 KDM4E (0.55) KDM4EALDH1A1TSHRSMN1; SMN2ABCC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100215735-A1 Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds MULLAN MICHAEL J 2010-08-26 — — US disclosed
US-20100215735-A1 Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds MULLAN MICHAEL J 2010-08-26 — — US disclosed
US-20100216784-A1 Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds MULLAN MICHAEL J 2010-08-26 — — US disclosed
US-20100216784-A1 Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds MULLAN MICHAEL J 2010-08-26 — — US disclosed
US-20100215735-A1 Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds MULLAN MICHAEL J 2010-08-26 — — US disclosed
US-20100216784-A1 Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds MULLAN MICHAEL J 2010-08-26 — — US disclosed
US-20100119599-A1 POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION ARCHER PHARMACEUTICALS, INC. (US) 2010-05-13 — — US disclosed
US-20100119599-A1 POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION ARCHER PHARMACEUTICALS, INC. (US) 2010-05-13 — — US disclosed
US-20100119599-A1 POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION ARCHER PHARMACEUTICALS, INC. (US) 2010-05-13 — — US disclosed
US-20080058330-A1 Compounds and Combinations Thereof for Inhibiting Beta-Amyloid Production and Methods of Use Thereof ROSKAMP RESEARCH LLC (US) 2008-03-06 — — US disclosed
US-20070191409-A1 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds ROSKAMP RESEARCH LLC 2007-08-16 — — US disclosed
US-20070185130-A1 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds ROSKAMP RESEARCH LLC 2007-08-09 — — US disclosed
US-20070185130-A1 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds ROSKAMP RESEARCH LLC 2007-08-09 — — US disclosed
US-20070185130-A1 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds ROSKAMP RESEARCH LLC 2007-08-09 — — US disclosed
US-20070037855-A1 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds ALZHEIMER'S INSTITUTE OF AMERICA, INC. 2007-02-15 — — US disclosed
US-20070037855-A1 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds ALZHEIMER'S INSTITUTE OF AMERICA, INC. 2007-02-15 — — US disclosed
US-20070037855-A1 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds ALZHEIMER'S INSTITUTE OF AMERICA, INC. 2007-02-15 — — US disclosed
US-20060188938-A1 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds ARCHER PHARMACEUTICALS, INC. 2006-08-24 — — US disclosed
US-5432185-A Treating patients exhibiting acute or chronic ischaemic disorders associated with disorders of microcirculation, without lowering or increasing blood pressure BAYER AKTIENGESELLSCHAFT (DE) 1995-07-11 — — US disclosed
US-5234935-A Preventing myocardial infarct BAYER AKTIENGESELLSCHAFT (DE) 1993-08-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058330-A1 Compounds and Combinations Thereof for Inhibiting Beta-Amyloid Production and Methods of Use Thereof APP, PSEN1, PSEN2 KDM4E 4629/4885ALDH1A1 3749/4885TSHR 4437/4885
US-20100119599-A1 POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION APP, MAPT, PSEN1 KDM4E 4115/4885ALDH1A1 2615/4885TSHR 4847/4885
US-20070191409-A1 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds APP, PSEN1, PSEN2 KDM4E 4759/4885ALDH1A1 3939/4885TSHR 4253/4885
US-20070185130-A1 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds APP, PSEN1, PSEN2 KDM4E 4759/4885ALDH1A1 3939/4885TSHR 4253/4885
US-20070037855-A1 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds APP, PSEN1, PSEN2 KDM4E 4759/4885ALDH1A1 3939/4885TSHR 4253/4885
US-20100216784-A1 Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds APP, PSEN1, PSEN2 KDM4E 4759/4885ALDH1A1 3939/4885TSHR 4253/4885
US-20060188938-A1 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds APP, PSEN1, PSEN2 KDM4E 4759/4885ALDH1A1 3939/4885TSHR 4253/4885
US-20100215735-A1 Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds APP, PSEN1, PSEN2 KDM4E 4759/4885ALDH1A1 3939/4885TSHR 4253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.